Healthcare -
Biotechnology - NASDAQ - NL
$ 20.93
-0.333 %
$ 2.3 B
Market Cap
-8.18
P/E
NAMS - OTHER CURRENT LIABILITIES
Other Current Liabilities NAMS - NewAmsterdam Pharma Company N.V.
24 M
LAST VALUE
327.60%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR